*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>(R)-tert-Butyl 3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate is a high-purity chiral intermediate synthesized via asymmetric catalysis. Its <strong>molecular formula</strong> is C<sub>25</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>, serving as a key scaffold for kinase inhibitor development.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical R&D:</strong> Precursor for novel BTK inhibitors targeting autoimmune disorders.</li>
<li><strong>Medicinal Chemistry:</strong> Used in SAR studies to optimize binding affinity and metabolic stability.</li>
<li><strong>API Manufacturing:</strong> Critical starting material for scaling up specific oncology drug candidates.</li>
</ul>
<h3>Precautions</h3>
<p>Store under inert atmosphere at -20°C to prevent racemization. Use appropriate PPE during handling due to potential mutagenicity. Strictly adhere to GMP guidelines for clinical trial supply chains.</p>